Statin treatment withdrawal in ischemic stroke: a controlled randomized study.

PubWeight™: 2.17‹?› | Rank: Top 2%

🔗 View Article (PMID 17724294)

Published in Neurology on August 28, 2007

Authors

M Blanco1, F Nombela, M Castellanos, M Rodriguez-Yáñez, M García-Gil, R Leira, I Lizasoain, J Serena, J Vivancos, M A Moro, A Dávalos, J Castillo

Author Affiliations

1: Department of Neurology, Hospital Clínico Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.

Associated clinical trials:

Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) (REPAIRS) | NCT02484027

Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery | NCT01186289

Articles citing this

Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes. Can Fam Physician (2013) 1.67

Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med (2014) 1.60

Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc (2008) 1.55

Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev (2012) 1.46

Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des (2012) 1.42

Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. Neurology (2016) 1.41

High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). Cerebrovasc Dis (2009) 1.10

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08

Cholesterol: its regulation and role in central nervous system disorders. Cholesterol (2012) 1.08

Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis (2008) 0.99

Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol (2010) 0.96

Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill. Chest (2011) 0.96

The THRombolysis and STatins (THRaST) study. Neurology (2013) 0.92

Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2. Antioxid Redox Signal (2012) 0.91

Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol (2011) 0.90

Early statin use is associated with increased risk of infection after stroke. J Stroke Cerebrovasc Dis (2011) 0.90

Statins in traumatic brain injury. Neurotherapeutics (2010) 0.89

The value of leukocyte adhesion molecules in patients after ischemic stroke. J Neurol (2009) 0.89

Sex differences in the prognostic value of the lipid profile after the first ischemic stroke. J Neurol (2009) 0.88

Statin discontinuation: counterbalancing the benefits with the potential risks. Arch Med Sci (2011) 0.87

Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke. Stroke (2011) 0.86

Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care (2011) 0.85

The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis. Lipids Health Dis (2012) 0.84

Statins in Acute Ischemic Stroke: A Systematic Review. J Stroke (2015) 0.83

Randomized clinical stroke trials in 2007. Open Neurol J (2008) 0.80

Modern medical management of acute ischemic stroke. Methodist Debakey Cardiovasc J (2014) 0.79

Statins and risk of poststroke hemorrhagic complications. Neurology (2016) 0.78

Association between statin use and short-term outcome based on severity of ischemic stroke: a cohort study. PLoS One (2014) 0.78

Drug discontinuation effects are part of the pharmacology of a drug. J Pharmacol Exp Ther (2011) 0.78

The role of statins in neurosurgery. Neurosurg Rev (2010) 0.78

The many roles of statins in ischemic stroke. Curr Neuropharmacol (2014) 0.77

Secondary stroke prevention strategies for the oldest patients: possibilities and challenges. Drugs Aging (2009) 0.77

Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2. Antioxid Redox Signal (2014) 0.77

Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. BMC Neurol (2015) 0.76

Unintentional discontinuation of statins may increase mortality after traumatic brain injury in elderly patients: a preliminary observation. J Clin Med Res (2013) 0.76

Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model. Curr Neurovasc Res (2012) 0.76

Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke. Int J Mol Sci (2016) 0.75

Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update. Wien Klin Wochenschr (2016) 0.75

Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke. J Cent Nerv Syst Dis (2017) 0.75

Update of secondary stroke prevention. Nephrol Dial Transplant (2009) 0.75

Re: Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology (2008) 0.75

Minor Stroke and Transient Ischemic Attack: Research and Practice. Front Neurol (2016) 0.75

Impact of Increased Early Statin Administration on Ischemic Stroke Outcomes: A Multicenter Electronic Medical Record Intervention. J Am Heart Assoc (2016) 0.75

Statin withdrawal beyond acute phase affected outcome of thrombolytic stroke patients: an observational retrospective study. Medicine (Baltimore) (2015) 0.75

Is statin discontinuation an option in patients who have had a stroke? Nat Clin Pract Neurol (2007) 0.75

The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Metab Brain Dis (2017) 0.75

Articles by these authors

Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke (2000) 3.74

Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology (2004) 3.21

Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A (1994) 2.70

Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39

Inflammation and liver cancer: new molecular links . Ann N Y Acad Sci (2009) 2.29

Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem (2008) 2.24

Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain (1997) 2.22

Influence of the stroke code activation source on the outcome of acute ischemic stroke patients. Neurology (2008) 2.17

cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1996) 2.17

Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05

Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology (1995) 1.97

[Endovascular treatment in acute ischaemic stroke. A stroke care plan for the region of Madrid]. Neurologia (2013) 1.97

[Efficacy of ondansetron in the prevention of nausea and vomiting after laparoscopic cholecystectomy]. Rev Esp Anestesiol Reanim (1997) 1.92

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest (1992) 1.82

Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke (1999) 1.80

Timing for fever-related brain damage in acute ischemic stroke. Stroke (1998) 1.68

Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol (2011) 1.66

An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. Cephalalgia (2001) 1.58

Poststroke dementia : clinical features and risk factors. Stroke (2000) 1.54

Molecular signatures of brain injury after intracerebral hemorrhage. Neurology (2002) 1.53

Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis. Eur J Neurol (2009) 1.53

[Spanish doctoral dissertations on anesthesiology and the scientific publications of their authors]. Rev Esp Anestesiol Reanim (2002) 1.51

Progression of ischaemic stroke and excitotoxic aminoacids. Lancet (1997) 1.49

Genetic markers: association study in migraine. Cephalalgia (1995) 1.48

Prevention of post dural puncture headache with epidural-administered dextran 40. Reg Anesth (1993) 1.48

[Problem/case-based learning compared to lectures for acquiring knowledge of air embolism in continuing medical education]. Rev Esp Anestesiol Reanim (2008) 1.47

A new method for kidney vascularization. Arch Surg (1968) 1.43

Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum (1994) 1.42

Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry (2005) 1.40

The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology (2004) 1.40

[Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery]. Rev Esp Anestesiol Reanim (2003) 1.40

[Experimental headache models]. Neurologia (2003) 1.40

Thrombocytopenia associated with carbamazepine: a case series. J Clin Psychiatry (1991) 1.39

[Delayed improvement of anemia treated with intravenous iron and epoetin alfa after hip replacement surgery]. Rev Esp Anestesiol Reanim (2005) 1.39

Role of nitric oxide after brain ischaemia. Cell Calcium (2004) 1.38

Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev (2003) 1.37

Wallerian degeneration in the corticospinal tract evaluated by diffusion tensor imaging correlates with motor deficit 30 days after middle cerebral artery ischemic stroke. AJNR Am J Neuroradiol (2010) 1.37

Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG-repeat in a large pedigree displaying anticipation and parental male bias. Hum Mol Genet (1993) 1.29

The capillarity of nanometric water menisci confined inside closed-geometry viral cages. Proc Natl Acad Sci U S A (2009) 1.27

Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology (2001) 1.25

Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J (1996) 1.24

Acute damage to the posterior limb of the internal capsule on diffusion tensor tractography as an early imaging predictor of motor outcome after stroke. AJNR Am J Neuroradiol (2011) 1.22

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax (2003) 1.22

Accessory vascularization to the kidney. Rev Surg (1968) 1.21

Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry (2005) 1.21

Duration of glutamate release after acute ischemic stroke. Stroke (1997) 1.19

Epidemiology of chronic daily headache. Curr Pain Headache Rep (2001) 1.19

Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke (1996) 1.17

Pyruvate carboxylase from Rhizobium etli: mutant characterization, nucleotide sequence, and physiological role. J Bacteriol (1996) 1.17

Expression of thiamin biosynthetic genes (thiCOGE) and production of symbiotic terminal oxidase cbb3 in Rhizobium etli. J Bacteriol (1997) 1.17

Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem (2001) 1.17

The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke (1998) 1.16

The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol (1995) 1.14

Central and peripheral corneal thickness in full-term newborns by ultrasonic pachymetry. Invest Ophthalmol Vis Sci (1992) 1.11

The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (2000) 1.11

Novel organization of the common nodulation genes in Rhizobium leguminosarum bv. phaseoli strains. J Bacteriol (1991) 1.11

Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis (2009) 1.10

Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol (2009) 1.09

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology (2009) 1.09

Differential regulation of fixN-reiterated genes in Rhizobium etli by a novel fixL-fixK cascade. Mol Plant Microbe Interact (2000) 1.09

Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett (2007) 1.08

Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J Rheumatol (1989) 1.08

Regulatory proteins and cis-acting elements involved in the transcriptional control of Rhizobium etli reiterated nifH genes. J Bacteriol (1996) 1.07

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. J Viral Hepat (2008) 1.07

[Cardiorespiratory arrest and afterwards what?]. Med Clin (Barc) (1999) 1.06

High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology (2008) 1.05

Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand (2007) 1.05

Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia (2006) 1.04

Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth (2011) 1.04

Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem (2000) 1.04

Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology (1996) 1.03

Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost (2005) 1.03

Embolism in acute middle cerebral artery stenosis. Neurology (2001) 1.03

Abscess caused by Salmonella enteritidis within a glioblastoma multiforme. J Infect (1987) 1.02